These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22900350)

  • 1. Rationalization of physico-chemical properties of 5, 6-diarylthiazolo [3,2-b]-1, 2, 4-triazoles towards cyclooxygenase-2 (COX-2) inhibition: a QSAR approach.
    Manivannan E; Prasanna S; Chaturvedi SC
    Indian J Biochem Biophys; 2004 Aug; 41(4):179-83. PubMed ID: 22900350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR studies on structurally similar 2-(4-methanesulfonylphenyl)pyran-4-ones as selective COX-2 inhibitors: a Hansch approach.
    Prasanna S; Manivannan E; Chaturvedi SC
    Bioorg Med Chem Lett; 2005 Jan; 15(2):313-20. PubMed ID: 15603946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR analyses of conformationally restricted 1,5-diaryl pyrazoles as selective COX-2 inhibitors: application of connection table representation of ligands.
    Prasanna S; Manivannan E; Chaturvedi SC
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2097-102. PubMed ID: 15808476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory mode of 2-acetoxyphenyl alkyl sulfides against COX-1 and COX-2: QSAR analyses.
    Jain HK; Mourya VK; Agrawal RK
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5280-4. PubMed ID: 16908140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and optimisation of a novel series of pyrimidine based cyclooxygenase-2 (COX-2) inhibitors. Utilisation of a biotransformation approach.
    Beswick PJ; Blackaby AP; Bountra C; Brown T; Browning K; Campbell IB; Corfield J; Gleave RJ; Guntrip SB; Hall RM; Hindley S; Lambeth PF; Lucas F; Mathews N; Naylor A; Player H; Price HS; Sidebottom PJ; Taylor NL; Webb G; Wiseman J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4509-14. PubMed ID: 19523822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspective assessment of COX-1 and COX-2 selectivity of nonsteroidal anti-inflammatory drugs from clinical practice: use of genetic function approximation.
    Zambre AP; Ganure AL; Shinde DB; Kulkarni VM
    J Chem Inf Model; 2007; 47(2):635-43. PubMed ID: 17256838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR analysis of meclofenamic acid analogues as selective COX-2 inhibitors.
    Narsinghani T; Chaturvedi SC
    Bioorg Med Chem Lett; 2006 Jan; 16(2):461-8. PubMed ID: 16290292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative structure activity relationship studies of diaryl furanones as selective COX-2 inhibitors.
    Shahapurkar S; Pandya T; Kawathekar N; Chaturvedi SC
    Eur J Med Chem; 2004 Apr; 39(4):383-8. PubMed ID: 15072847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QSAR analysis of 1,3-diaryl-4,5,6,7-tetrahydro-2H-isoindole derivatives as selective COX-2 inhibitors.
    Silakari P; Shrivastava SD; Silakari G; Kohli DV; Rambabu G; Srivastava S; Shrivastava SK; Silakari O
    Eur J Med Chem; 2008 Jul; 43(7):1559-69. PubMed ID: 18023931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and cyclooxygenase inhibition of various (aryl-1,2,3-triazole-1-yl)-methanesulfonylphenyl derivatives.
    Wuest F; Tang X; Kniess T; Pietzsch J; Suresh M
    Bioorg Med Chem; 2009 Feb; 17(3):1146-51. PubMed ID: 19157881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure-activity relationship for anti-inflammatory drug.
    Hayashi S; Ueno N; Murase A; Nakagawa Y; Takada J
    Eur J Med Chem; 2012 Apr; 50():179-95. PubMed ID: 22373734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,4-Diaryl-substituted triazoles as cyclooxygenase-2 inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Kaur J; Bhardwaj A; Sharma SK; Wuest F
    Bioorg Med Chem; 2013 Jul; 21(14):4288-95. PubMed ID: 23706267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercinol, an anti-inflammatory chromene from the wood-rotting fungus Daedalea quercina (Oak Mazegill).
    Gebhardt P; Dornberger K; Gollmick FA; Gräfe U; Härtl A; Görls H; Schlegel B; Hertweck C
    Bioorg Med Chem Lett; 2007 May; 17(9):2558-60. PubMed ID: 17346963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of new 1,3-benzthiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
    Zarghi A; Zebardast T; Daraie B; Hedayati M
    Bioorg Med Chem; 2009 Aug; 17(15):5369-73. PubMed ID: 19596198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative structure-activity relationship studies of 1-(5-methylsulfonylpyrid-2-yl)-5-alkyl and (hetero)aryl triazoles and pyrazoles in canine COX inhibition.
    Sakya SM; Shavnya A; Cheng H; Li C; Rast B; Li J; Koss DA; Jaynes BH; Mann DW; Petras CF; Seibel SB; Haven ML; Lynch MP
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1042-5. PubMed ID: 18182290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QSAR of 2-(4-methylsulphonylphenyl)pyrimidine derivatives as cyclooxygenase-2 inhibitors: simple structural fragments as potential modulators of activity.
    Sharma BK; Singh P; Pilania P; Shekhawat M; Prabhakar YS
    J Enzyme Inhib Med Chem; 2012 Apr; 27(2):249-60. PubMed ID: 21679051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New NSAIDs-NO hybrid molecules with antiproliferative properties on human prostatic cancer cell lines.
    Bézière N; Goossens L; Pommery J; Vezin H; Touati N; Hénichart JP; Pommery N
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4655-7. PubMed ID: 18667313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel quinoline incorporating 1,2,4-triazole/oxime hybrids: Synthesis, molecular docking, anti-inflammatory, COX inhibition, ulceroginicity and histopathological investigations.
    Mohassab AM; Hassan HA; Abdelhamid D; Abdel-Aziz M; Dalby KN; Kaoud TS
    Bioorg Chem; 2017 Dec; 75():242-259. PubMed ID: 29032325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D-QSAR and preliminary evaluation of anti-inflammatory activity of series of N-pyrrolylcarboxylic acids.
    Lessigiarska I; Nankov A; Bocheva A; Pajeva I; Bijev A
    Farmaco; 2005 Mar; 60(3):209-18. PubMed ID: 15784239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and SAR/3D-QSAR studies on the COX-2 inhibitory activity of 1,5-diarylpyrazoles to validate the modified pharmacophore.
    Singh SK; Saibaba V; Rao KS; Reddy PG; Daga PR; Rajjak SA; Misra P; Rao YK
    Eur J Med Chem; 2005 Oct; 40(10):977-90. PubMed ID: 15961192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.